SCH-51866
![]() | |
| Names | |
|---|---|
| IUPAC name
(6aR,9aS)-5-Methyl-2-[4-(trifluoromethyl)benzyl]-5,6a,7,8,9,9a-hexahydrocyclopenta[4,5]imidazo[2,1-b]purin-4(3H)-one | |
| Identifiers | |
| ChemSpider | 26377910 |
| 5270 | |
| Jmol interactive 3D | Image |
| PubChem | 15473392 |
| |
| |
| Properties | |
| C19H18F3N5O | |
| Molar mass | 389.38 g·mol−1 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
SCH-51866 is a phosphodiesterase inhibitor.[1][2]
References
- ↑ "cGMP-phosphodiesterase antagonists inhibit Ca2+-influx in Dictyostelium discoideum and bovine cyclic-nucleotide-gated-channel". Eur. J. Pharmacol. 513 (1-2): 9–20. April 2005. doi:10.1016/j.ejphar.2005.01.047. PMID 15878705.
- ↑ Beaumont V, Park L, Rassoulpour A, et al. (2014). "The PDE1/5 Inhibitor SCH-51866 Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's Disease". PLoS Curr 6. doi:10.1371/currents.hd.3304e87e460b4bb0dc519a29f4deccca. PMC 3923778. PMID 24558637.

This article is issued from Wikipedia - version of the Wednesday, September 02, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
